1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Kidney Cancer Therapeutics and Diagnostics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Component
6.1 Drugs
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Drugs by Therapeutic Class
6.1.2.1.1 Targeted Therapy
6.1.2.1.2 Immunotherapy
6.1.2.1.3 Others
6.1.2.2 Drugs by Pharmacologic Class
6.1.2.2.1 Angiogenesis Inhibitors
6.1.2.2.2 mTOR Inhibitors
6.1.2.2.3 Monoclonal Antibodies
6.1.2.2.4 Cytokine Immunotherapy (II-2)
6.1.3 Market Forecast
6.2 Diagnostics
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Imaging Test
6.2.2.2 Biopsy
6.2.2.3 Blood Test
6.2.2.4 Others
6.2.3 Market Forecast
7 Market Breakup by Cancer Types
7.1 Clear Cell RCC
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Papillary RCC
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Chromophobe RCC
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Transitional Cell Carcinoma
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmaceutical Labs
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Genomics Laboratories
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 Drivers, Restraints, and Opportunities
10.1 Overview
10.2 Drivers
10.3 Restraints
10.4 Opportunities
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Bristol-Myers Squibb Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Exelixis Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Genentech Inc. (Roche Holding AG)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 Novartis AG
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Pfizer Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
List of Figures
Figure 1: Global: Kidney Cancer Therapeutics and Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Component (in %), 2023
Figure 5: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Cancer Types (in %), 2023
Figure 6: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Application (in %), 2023
Figure 7: Global: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Region (in %), 2023
Figure 8: Global: Kidney Cancer Therapeutics and Diagnostics (Drugs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Kidney Cancer Therapeutics and Diagnostics (Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Kidney Cancer Therapeutics and Diagnostics (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Kidney Cancer Therapeutics and Diagnostics (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Kidney Cancer Therapeutics and Diagnostics (Clear Cell RCC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Kidney Cancer Therapeutics and Diagnostics (Clear Cell RCC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Kidney Cancer Therapeutics and Diagnostics (Papillary RCC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Kidney Cancer Therapeutics and Diagnostics (Papillary RCC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Kidney Cancer Therapeutics and Diagnostics (Chromophobe RCC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Kidney Cancer Therapeutics and Diagnostics (Chromophobe RCC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Kidney Cancer Therapeutics and Diagnostics (Transitional Cell Carcinoma) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Kidney Cancer Therapeutics and Diagnostics (Transitional Cell Carcinoma) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Kidney Cancer Therapeutics and Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Kidney Cancer Therapeutics and Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Kidney Cancer Therapeutics and Diagnostics (Pharmaceutical Labs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Kidney Cancer Therapeutics and Diagnostics (Pharmaceutical Labs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Kidney Cancer Therapeutics and Diagnostics (Genomics Laboratories) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Kidney Cancer Therapeutics and Diagnostics (Genomics Laboratories) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Kidney Cancer Therapeutics and Diagnostics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Kidney Cancer Therapeutics and Diagnostics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Kidney Cancer Therapeutics and Diagnostics Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Kidney Cancer Therapeutics and Diagnostics Industry: Drivers, Restraints, and Opportunities
Figure 80: Global: Kidney Cancer Therapeutics and Diagnostics Industry: Value Chain Analysis
Figure 81: Global: Kidney Cancer Therapeutics and Diagnostics Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Kidney Cancer Therapeutics and Diagnostics Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Component (in Million US$), 2024-2032
Table 3: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Cancer Types (in Million US$), 2024-2032
Table 4: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Kidney Cancer Therapeutics and Diagnostics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Kidney Cancer Therapeutics and Diagnostics Market: Competitive Structure
Table 7: Global: Kidney Cancer Therapeutics and Diagnostics Market: Key Players